|
| References | Country | Disease type | Participant (male/female) | Age (years) | Interventions and time | Intervention length, frequency, and duration | Needed outcomes |
| Sum | EG | CG | EG | CG | EG | CG | EG | CG |
|
| Xiong et al. [24] | China | CGH | 124 | 62 (27/35) | 62 (29/33) | 41.6 ± 7.8 | 38.7 ± 6.3 | MFR + Mulligan’s mobilization + drug therapy | Drug therapy | The control group was treated with the same basic drugs + for 10 days, and fascia manual release combined with dynamic joint loosening was treated once a day | Celecoxib gum 200 mg once a day, eperisone hydrochloride tablet 50 mg 3 times a day, compound danshen tablet 960 mg 3 times a day. The duration of treatment was 10 days | Pain (VAS) |
|
| Shrivastava et al. [25] | India | CGH | 30 | 15 (unspecified) | 15 (unspecified) | | | MFR + physiotherapy program | Physiotherapy program | Five times a week for six weeks | Five times a week for six weeks | Pain (VAS), disability (NDI) |
|
| Shabbir et al. [26] | Pakistan | CGH | 22 | 11 (3/8) | 11 (4/7) | 30.63 ± 4.90 | 33.18 ± 3.62 | MFR + physiotherapy program | SNAG technique + Physiotherapy program | Three times a week for six weeks | Three times a week for six weeks | Pain (NRS) disability (NDI) |
|
| Espí-López et al. [27] | Spain | Migraine | 46 | 23 (1/22) | 23 (7/16) | 33.9 ± 11.5 | 33.9 ± 11.5 | MFR + physiotherapy program (30 min) | Physiotherapy program (30 min) | 8 weeks, 4 sessions (once every 15 days) | 8 weeks, 4 sessions (once every 15 days) | Disability (HIT-6,MIDAS) |
|
| Hosseinifar et al. [28] | Iran | TTH | 30 | 15 (female) | 15 (female) | 25.06 ± 7.64 | 29.33 ± 11.63 | MFR + exercise (45 minutes) | No intervention | Four times a week for three weeks | | Pain (NRS) disability (HDI) |
|
| Cho et al. [29] | Korea | TTH | 60 | 16 (5/11) | 17 (5/12) | 33.23 ± 8.74 | 38.07 ± 10.94 | MFR (15 minutes) | No intervention | Twice a week, 4 weeks/twice a week, 4 weeks + 3 extra training sessions at home | | Disability (NDI) |
| 15 (4/11) | 35.56 ± 8.57 | MFR (15 minutes) + exercise |
|
| Corum et al. [30] | Turkey | TTH | 30 | 15 (4/11) | 12 (4/8) | 30.7 ± 8.0 | 32.5 ± 6.5 | MFR (10 minutes) + exercise | Exercise | MFR for twice a week and exercise for three times a week, 4 weeks | Three times a week, 4 weeks | Pain (VAS), disability (NDI,HIT-6) |
| Azhdari et al. [31] | Iran | TTH | 24 | 12 (5/7) | 12 (4/8) | 43.16 | 41.41 | MFR + mobilization + drug therapy (30 min) | Drug therapy | Three therapy sessions for one week | Nortriptyline 50 qsh and valporae Na 200 mg BID | Pain (NRS) disability (NDI) |
|
| Cho et al. [32] | Korea | TTH | 45 | 14 (3/11) | 13 (3/10) | 36.60 ± 8.33 | 39.07 ± 10.99 | MFR (15 minutes) | No intervention | Twice a week, 4 weeks/twice a week, 4 weeks + 3 extra training sessions at home | | Disability (HIT-6) |
| 14 (4/10) | 36.00 ± 8.47 | MFR (15 minutes) + exercise |
|
| Mosallanezhad et al. [33] | USA | Migraine | 40 | 20 (12/8) | 20 (12/8) | 40.4 ± 11.2 | 37.45 ± 8.9 | MFR + stretch (20 minutes) | Placebo-control | Three times a week for two weeks | Three times a week for two weeks | Pain (VAS) disability (NDI) |
|
